Advertisement
Screener

Serina Therapeutics, Inc. (SER) Net Income (Loss) Attributable to Noncontrolling Interest

1.4 / 5 stars · 16/57 Roast Me

Serina Therapeutics, Inc. Net Income (Loss) Attributable to Noncontrolling Interest

Serina Therapeutics, Inc. (SER) reported Net Income (Loss) Attributable to Noncontrolling Interest of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Income Statement › Net Income

us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2026-08-13

  • Serina Therapeutics, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-06-30 was $0.00.
  • Serina Therapeutics, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-03-31 was $0.00.
  • Serina Therapeutics, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-12-31 was $0.00.
  • Serina Therapeutics, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-09-30 was -$10.00K.
  • Serina Therapeutics, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2025 was -$33.00K.
  • Serina Therapeutics, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2024 was -$66.00K.
  • Serina Therapeutics, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2023 was $0.00.
  • Serina Therapeutics, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2022 was -$60.00K.
Period endNet Income (Loss) Attributable to Noncontrolling Interest 3 monthNet Income (Loss) Attributable to Noncontrolling Interest 3 month as first filedNet Income (Loss) Attributable to Noncontrolling Interest 6 monthNet Income (Loss) Attributable to Noncontrolling Interest 6 month as first filedNet Income (Loss) Attributable to Noncontrolling Interest 9 monthNet Income (Loss) Attributable to Noncontrolling Interest 9 month as first filedNet Income (Loss) Attributable to Noncontrolling Interest 12 monthNet Income (Loss) Attributable to Noncontrolling Interest 12 month as first filed
2026-06-30$0.00
10-Q · filed 2026-08-13
$0.00
10-Q · filed 2026-08-13
$0.00
derived: sum of 3 quarters · filed 2026-08-13
-$10.00K
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31$0.00
10-Q · filed 2026-05-14
$0.00
derived: sum of 2 quarters · filed 2026-05-14
-$10.00K
derived: sum of 3 quarters · filed 2026-05-14
-$24.00K
derived: sum of 4 quarters · filed 2026-08-13
2025-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
-$10.00K
derived: sum of 2 quarters · filed 2026-03-25
-$24.00K
derived: sum of 3 quarters · filed 2026-08-13
-$33.00K
10-K · filed 2026-03-25
2025-09-30-$10.00K
10-Q · filed 2025-11-13
-$24.00K
derived: sum of 2 quarters · filed 2026-08-13
-$33.00K
10-Q · filed 2025-11-13
-$45.00K
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30-$14.00K
10-Q · filed 2026-08-13
-$23.00K
10-Q · filed 2026-08-13
-$35.00K
derived: sum of 3 quarters · filed 2026-08-13
-$62.00K
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31-$9.00K
10-Q · filed 2026-05-14
-$21.00K
derived: sum of 2 quarters · filed 2026-05-14
-$48.00K
derived: sum of 3 quarters · filed 2026-05-14
-$75.00K
derived: sum of 4 quarters · filed 2026-05-14
2024-12-31-$12.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
-$39.00K
derived: sum of 2 quarters · filed 2026-03-25
-$66.00K
derived: sum of 3 quarters · filed 2026-03-25
-$66.00K
10-K · filed 2026-03-25
2024-09-30-$27.00K
10-Q · filed 2025-11-13
-$54.00K
derived: sum of 2 quarters · filed 2025-11-13
-$54.00K
10-Q · filed 2025-11-13
-$54.00K
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30-$27.00K
10-Q · filed 2025-08-11
-$27.00K
10-Q · filed 2025-08-11
-$27.00K
derived: sum of 3 quarters · filed 2025-08-11
-$27.00K
derived: sum of 4 quarters · filed 2025-08-11
2024-03-31$0.00
10-Q · filed 2025-05-08
$0.00
derived: sum of 2 quarters · filed 2025-05-08
$0.00
derived: sum of 3 quarters · filed 2025-05-08
-$10.00K
derived: sum of 4 quarters · filed 2025-05-08
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24
$0.00
derived: sum of 2 quarters · filed 2025-03-24
-$10.00K
derived: sum of 3 quarters · filed 2025-03-24
$0.00
10-K · filed 2025-03-24
-$8.00K
10-K · filed 2024-03-22
2023-09-30$0.00
10-Q · filed 2024-11-12
$12.00K
10-Q · filed 2023-11-14
-$10.00K
derived: sum of 2 quarters · filed 2024-11-12
$0.00
10-Q · filed 2024-11-12
-$6.00K
10-Q · filed 2023-11-14
-$76.00K
derived: sum of 4 quarters · filed 2024-11-12
2023-06-30-$10.00K
10-Q · filed 2023-08-14
-$18.00K
10-Q · filed 2023-08-14
-$76.00K
derived: sum of 3 quarters · filed 2024-03-22
-$77.00K
derived: sum of 4 quarters · filed 2024-03-22
2023-03-31-$8.00K
10-Q · filed 2023-05-12
-$66.00K
derived: sum of 2 quarters · filed 2024-03-22
-$67.00K
derived: sum of 3 quarters · filed 2024-03-22
-$67.00K
derived: sum of 4 quarters · filed 2024-03-22
2022-12-31-$58.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22
-$59.00K
derived: sum of 2 quarters · filed 2024-03-22
-$59.00K
derived: sum of 3 quarters · filed 2024-03-22
-$60.00K
10-K · filed 2024-03-22
2022-09-30-$1.00K
10-Q · filed 2023-11-14
-$1.00K
derived: sum of 2 quarters · filed 2023-11-14
-$2.00K
10-Q · filed 2023-11-14
-$3.00K
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
-$1.00K
10-Q · filed 2023-08-14
-$2.00K
derived: sum of 3 quarters · filed 2023-08-14
-$2.00K
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31-$1.00K
10-Q · filed 2023-05-12
-$2.00K
derived: sum of 2 quarters · filed 2023-05-12
-$2.00K
derived: sum of 3 quarters · filed 2023-05-12
-$3.00K
derived: sum of 4 quarters · filed 2023-05-12
2021-12-31-$1.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
-$1.00K
derived: sum of 2 quarters · filed 2023-03-31
-$2.00K
derived: sum of 3 quarters · filed 2023-03-31
-$3.00K
10-K · filed 2023-03-31
2021-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
-$1.00K
derived: sum of 2 quarters · filed 2022-11-10
-$2.00K
10-Q · filed 2022-11-10
-$110.00K
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30-$1.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12
-$2.00K
10-Q · filed 2022-08-12
-$110.00K
derived: sum of 3 quarters · filed 2022-08-12
-$132.00K
derived: sum of 4 quarters · filed 2022-08-12
2021-03-31-$1.00K
10-Q · filed 2022-05-13
-$109.00K
derived: sum of 2 quarters · filed 2022-05-13
-$131.00K
derived: sum of 3 quarters · filed 2022-05-13
-$173.00K
derived: sum of 4 quarters · filed 2022-05-13
2020-12-31-$108.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31
-$130.00K
derived: sum of 2 quarters · filed 2021-03-31
-$172.00K
derived: sum of 3 quarters · filed 2021-03-31
-$111.00K
10-K · filed 2021-03-31
2020-09-30-$22.00K
10-Q · filed 2020-11-16
-$64.00K
derived: sum of 2 quarters · filed 2020-11-16
-$3.00K
10-Q · filed 2021-11-12
-$99.00K
10-Q · filed 2020-11-16
-$129.00K
derived: sum of 4 quarters · filed 2021-03-31
2020-06-30-$42.00K
10-Q · filed 2020-08-14
-$1.00K
10-Q · filed 2021-08-13
-$77.00K
10-Q · filed 2020-08-14
-$107.00K
derived: sum of 3 quarters · filed 2021-03-31
-$163.00K
derived: sum of 4 quarters · filed 2021-03-31
2020-03-31-$35.00K
10-Q · filed 2020-05-14
-$65.00K
derived: sum of 2 quarters · filed 2021-03-31
-$121.00K
derived: sum of 3 quarters · filed 2021-03-31
-$187.00K
derived: sum of 4 quarters · filed 2021-03-31
2019-12-31-$30.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31
-$86.00K
derived: sum of 2 quarters · filed 2021-03-31
-$152.00K
derived: sum of 3 quarters · filed 2021-03-31
-$230.00K
10-K · filed 2021-03-31
2019-09-30-$56.00K
10-Q · filed 2020-11-16
-$122.00K
derived: sum of 2 quarters · filed 2020-11-16
-$200.00K
10-Q · filed 2020-11-16
-$288.00K
derived: sum of 4 quarters · filed 2020-11-16
2019-06-30-$66.00K
10-Q · filed 2020-08-14
-$144.00K
10-Q · filed 2020-08-14
-$232.00K
derived: sum of 3 quarters · filed 2020-08-14
-$266.00K
derived: sum of 4 quarters · filed 2020-08-14
2019-03-31-$78.00K
10-Q · filed 2020-05-14
-$166.00K
derived: sum of 2 quarters · filed 2020-05-14
-$200.00K
derived: sum of 3 quarters · filed 2020-05-14
-$221.00K
derived: sum of 4 quarters · filed 2020-05-14
2018-12-31-$88.00K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-03-31
-$122.00K
derived: sum of 2 quarters · filed 2020-03-31
-$143.00K
derived: sum of 3 quarters · filed 2020-03-31
-$229.00K
10-K/A · filed 2020-03-31
2018-09-30-$34.00K
10-Q · filed 2019-11-14
-$55.00K
derived: sum of 2 quarters · filed 2019-11-14
-$141.00K
10-Q · filed 2019-11-14
2018-06-30-$21.00K
10-Q · filed 2019-08-14
-$107.00K
10-Q · filed 2019-08-14
2018-03-31-$86.00K
10-Q · filed 2019-05-15
2017-12-31-$57.00K
10-K · filed 2019-04-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
Clene Inc. (CLNN)United States$0.054B-1.99
HERON THERAPEUTICS, INC. /DE/ (HRTX)United States$0.055B-2.38
Xilio Therapeutics, Inc. (XLO)United States$0.052B
Annovis Bio, Inc. (ANVS)United States$0.056B-1.58
NOMAD POWER SOLUTIONS, INC. (NMAD)United States$0.058B
Boundless Bio, Inc. (BOLD)United States$0.059B-0.88
Elicio Therapeutics, Inc. (ELTX)United States$0.049B
Lite Strategy, Inc. (LITS)United States$0.049B
Dogwood Therapeutics, Inc. (DWTX)United States$0.049B
TALPHERA, INC. (TLPH)United States$0.060B